六周内分期对侧全髋关节置换术较单侧手术增加不良事件风险
研究基于2015至2020年全国数据库273,281例择期初次全髋关节置换术患者,其中39,905例(14.6%)为双侧手术。将同期双侧及分期双侧(1-14天、15-42天、43-90天、91-365天)与匹配的单侧病例比较第二侧术后90天结局,发现同期双侧及42天内分期对侧手术不良事件风险升高,而超过42天分期则风险相似或降低。
要点
- 同期双侧全髋关节置换术较单侧输血(OR 4.43)、再入院(OR 2.60)及任何并发症(OR 1.86)风险升高。
- 1-14天分期对侧手术较单侧再入院(OR 1.83)及任何并发症(OR 1.45)风险升高。
- 15-42天分期对侧手术较单侧假体周围感染(OR 3.15)、再入院(OR 1.92)及任何并发症(OR 1.70)风险升高。
核心结论
- 双侧全髋关节置换术在适当选择的患者中应至少间隔6周分期进行,以避免第二侧术后不良事件风险较单侧手术升高。
研究设计与样本
- 回顾性分析2015至2020年全国数据库中的择期初次全髋关节置换术患者,共识别273,281例,其中39,905例(14.6%)为双侧手术。
- 患者分为单侧全髋关节置换术、同期双侧全髋关节置换术及分期双侧全髋关节置换术(1-14天、15-42天、43-90天、91-365天)队列。
- 双侧队列按人口学特征和合并症与单侧全髋关节置换术患者进行匹配,比较第二侧术后90天结局。
主要发现
- 同期双侧全髋关节置换术较单侧输血风险升高(OR 4.43,95%CI 2.31-2.63,P < .001)、再入院风险升高(OR 2.60,95%CI 2.01-3.39,P < .001)及任何并发症风险升高(OR 1.86,95%CI 1.55-2.24,P < .001)。
- 1-14天分期对侧全髋关节置换术较单侧再入院风险升高(OR 1.83,95%CI 1.49-2.24,P < .001)及任何并发症风险升高(OR 1.45,95%CI 1.26-1.66,P < .001)。
- 15-42天分期对侧全髋关节置换术较单侧假体周围感染风险升高(OR 3.15,95%CI 1.98-5.19,P < .001)、再入院风险升高(OR 1.92,95%CI 1.55-2.39,P < .001)及任何并发症风险升高(OR 1.70,95%CI 1.46-1.97,P < .001)。
- 超过42天分期对侧全髋关节置换术较单侧不良事件发生率相似或降低。
关键数值与推荐
- 同期双侧全髋关节置换术较单侧:输血OR 4.43(95%CI 2.31-2.63,P < .001)、再入院OR 2.60(95%CI 2.01-3.39,P < .001)、任何并发症OR 1.86(95%CI 1.55-2.24,P < .001)。
- 1-14天分期对侧全髋关节置换术较单侧:再入院OR 1.83(95%CI 1.49-2.24,P < .001)、任何并发症OR 1.45(95%CI 1.26-1.66,P < .001)。
- 15-42天分期对侧全髋关节置换术较单侧:假体周围感染OR 3.15(95%CI 1.98-5.19,P < .001)、再入院OR 1.92(95%CI 1.55-2.39,P < .001)、任何并发症OR 1.70(95%CI 1.46-1.97,P < .001)。
- 超过42天分期对侧全髋关节置换术较单侧不良事件发生率相似或降低。
临床怎么用
- 作者认为,双侧全髋关节置换术在适当选择的患者中应至少间隔6周分期进行,以避免第二侧术后不良事件风险较单侧手术升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ideal timing for bilateral total hip arthroplasty (THA) remains controversial. This study compared 90-day outcomes after simultaneous bilateral THA and contralateral surgery in staged bilateral THA to a matched cohort of unilateral procedures. METHODS: Patients undergoing primary, elective THA during 2015 to 2020 were reviewed in a national database. Of the 273,281 patients identified, 39,905 (14.6%) were bilateral. Patients were divided into cohorts of unilateral THA, simultaneous bilateral THA, and staged bilateral THA at 1 to 14 days, 15 to 42 days, 43 to 90 days, and 91 to 365 days. Bilateral THA cohorts were matched with unilateral THA patients based on demographics and comorbidities. Ninety-day outcomes after the second THA were compared between matched groups. RESULTS: Simultaneous bilateral THA resulted in higher rates of transfusion (odds ratio [OR] 4.43, 95% confidence interval 2.31-2.63, P < .001), readmission (OR 2.60, 2.01-3.39, P < .001), and any complication (OR 1.86, 1.55-2.24, P < .001) compared to unilateral THA. Contralateral THA staged at 1 to 14 days increased the risk of readmission (OR 1.83, 1.49-2.24, P < .001) and any complication (OR 1.45, 1.26-1.66, P < .001) relative to unilateral THA. Contralateral THA staged at 15 to 42 days increased the risk of periprosthetic joint infection (OR 3.15, 1.98-5.19, P < .001), readmission (OR 1.92, 1.55-2.39, P < .001), and any complication (OR 1.70, 1.46-1.97, P < .001). Contralateral THA staged beyond 42 days resulted in similar or decreased rates of adverse events relative to unilateral THA. CONCLUSIONS: Bilateral THA should be staged a minimum of 6 weeks apart in appropriately selected patients to avoid an increased risk of adverse events after the second THA compared to unilateral THA.
引用
- Serino J, Terhune EB, Burnett RA, et al. Contralateral Total Hip Arthroplasty Staged Within Six Weeks Increases the Risk of Adverse Events Compared to Unilateral Surgery. J Arthroplasty. 2022. PMID: 36529192. doi:10.1016/j.arth.2022.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。